Einsatz von Gadoteridol in der MR-Diagnostik rheumatoider Gelenkveränderungen

Radiologe

Volumn 36, Issue 2, 1996, Pages 141-147

  Link, T M ^a   Bongartz, G M ^a   Boger K ^a   Daldrup, Heike ^a   Schmitz Linneweber, B ^a   Peters, P E ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE; GADOTERIDOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 3 CLINICAL TRIAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HETEROCYCLIC COMPOUNDS; HUMANS; JOINTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID;

EID: 0029864717     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001170050051     Document Type: Article

References (27)

1. Ball WS Jr, Nadel SN, Zimmerman RA, Byrd SE, Dietrich RB, Prenger EC, Drayer BP, Nelson MD Jr, Morgan FW, Altman NR (1993) Phase III multicenter clinical investigation to determine the safety and efficacy of gadoteridol in children suspected of having neurologic disease. Radiology 186: 769-74
2. Beltran J, Caudill JL, Hermann LA, Kantor SM, Hudson PN, Noto AM, Baran AS (1987) Rheumatoid arthritis: MR imaging manifestations. Radiology 165: 153-157
3. Buckland-Wright J.C. (1983) X-ray assessment of activity in rheumatoid disease. Br J Rheumatol 22: 3-10
4. Dihlmann W (1987) Gelenke und Wirbelverbindungen, 3. Aufl. Thieme, Stuttgart New York
5. Drayer BP (1993) MR imaging advances in practice. J Comput Assist Tomogr 17 [Suppl 1]: S30-5
6. Erlemann R, Reiser M, Peters PE, Wuismann P, Niendorf HP, Kunze V (1988) Zeitabhängige Änderungen der Signalintensitäten in neoplastischen und entzündlichen Läsionen des Bewegungsapparates nach i.v. Gabe von Gd-DTPA. Radiologe 28: 269-276
7. Erlemann R, Sciuk J, Wuisman P, Bene D, Edel G, Ritter J, Peters PE (1992) Dynamische MR-Tomographie in der Diagnostik entzündlicher und tumoroser Raumforderungen des muskuloskelettalen Systems. Fortschr Röntgenstr 156: 353-359
8. Erlemann R, Vassallo P, Bongartz G, Müller-Miny H, Rummeny E, Stöber U, Peters PE (1990) Musculoskeletal neoplasms: Fast low-angle shot MR Imaging with and without Gd-DTPA. Radiology 176: 489-495
9. Flecher BD, Hanna SL, Fairclough DL, Gronemeyer SA (1992) Pediatric musculoskeletal tumors: Use of dynamic, contrast-enhanced MR Imaging to monitor response to chemotherapy. Radiology 184: 243-248
10. König H, Sieper J, Wolf KJ (1990) Rheumatoid arthritis: Evaluation of hypervascular and fibrous pannus with dynamic MR Imaging enhanced with Gd-DTPA. Radiology 176: 473-477
11. König H, Bolze X, Sieper J, Wolf K-J (1992) Quantitativ evaluierte dynamische Magnetresonanztomographie bei chronischer Polyarthritis des Kniegelenkes. Fortschr Röntgenstr 157: 140-144
12. Müller W, Schilling F (1977) Differentialdiagnose rheumatischer Erkrankungen. Aesopus, München
13. Olukotun AY, Parker JR Meeks MJ, Lucas MA, Fowler DR, Lucas TR (1995) Safety of gadoteridol injection: U. S. clinical trial experience. JMRI 5: 17-25
14. Reiser M, Bongartz G, Erlemann R, Schneider M, Pauly T, Sittek H, Peters PE (1989) Gadolinium-DTPA in rheumatoid arthritis and related diseases: first results with magnetic resonance imaging. Skelet Radiol 18: 591-597
15. Renner WR, Weinstein AS (1988) Early changes of rheumatoid arthritis in the hand and wrist. Radiol Clin North Am 26: 1185-1193
16. Runge VM (1992) Magnetic resonance imaging contrast agents [editorial]. Curr Opin Radio 14: 3-12
17. Runge VM, Dean B, Lee C, Carolan F, Heard G (1991) Phase III clinical evaluation of Gd-HP-DO3A in head and spine disease. J Magn Reson Imaging 1: 47-56
18. Runge VM, Kirsch JE, Burke V, Price AC, Nelson KL, Thomas GS, Dean BL, Lee C (1992) High-dose gadoteridol in MR imaging of intracranial neoplasms. J Magn Reson Imaging 2: 9-18
19. Runge VM, Kirsch JE, Thomas GS (1991) High-dose applications of gadolinium chelates in magnetic resonance imaging. Magn Reson Med 22: 358-363
20. Runge VM, Bradley WG, Brant-Zawadzki MN, Carvlin MJ, DeSimone DN, Dean BL, Dilion WP, Drayer BP, Flanders AE, Harms SE et al (1991) Clinical safety and efficacy of Gadoteridol: A study of 411 patients with suspected intracranial and spinal disease. Radiology 181: 701-709
21. Shellock FG, Hahn HP, Mink JH, Itskovich E (1993) Adverse reaction to intravenous gadoteridol. Radiology 189: 151-152
22. Uno K, Suguro T, Nohira K, Moriya H, Saegusa K, Anzai Y, Terauchi T, Sato K, Uematsu S, Arimuzu N (1992) Comparison of Indium-111-labeled leukocyte scintigraphy and Technetium-99m joint scintigraphy in rheumatoid arthritis and osteoarthritis. Ann Nucl Med 6: 247-251
23. Wedeking P, Kumar K, Tweedle MF (1992) Dissociation of gadolinium chelates in mice: relationship to chemical characteristics. Magn Reson Imaging 10: 641-8
24. Weinblatt ME, Polisson R, Blotner SD, Sosman JL, Aliabadi P, Baker N, Weissman BN (1993) The effects of drug therapy on radiographic progression of rheumatoid arthritis. Arthritis Rheum 36: 613-619
25. Weinbiatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN, Trentham DE (1985) Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 312: 818-822
26. Yuh WT, Fisher DJ, Engelken JD, Greene GM, Sato Y, Ryals TJ, Crain MR, Ehrhardt JC (1991) MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol. Radiology 180: 485-91
27. Zoarski GH, Lufkin RB, Bradley WG Jr, Handers AE, Gale DR, Harms SE, Haughton VM, Joy SE, Kanal E, Rosa L (1993) Multicenter trial of gadoteridol, a nonionic gadolinium chelate, in patients with suspected head and neck pathology. Am J Neuroradiol 14: 955-61